Title | A Diagnosis for All Rare Genetic Diseases: The Horizon and the Next Frontiers. |
Publication Type | Journal Article |
Year of Publication | 2019 |
Authors | Boycott, KM, Hartley, T, Biesecker, LG, Gibbs, RA, A Innes, M, Riess, O, Belmont, J, Dunwoodie, SL, Jojic, N, Lassmann, T, Mackay, D, I Temple, K, Visel, A, Baynam, G |
Journal | Cell |
Volume | 177 |
Issue | 1 |
Pagination | 32-37 |
Date Published | 2019 Mar 21 |
ISSN | 1097-4172 |
Keywords | Exome, Exome Sequencing, Genetic Testing, Genome, Human, High-Throughput Nucleotide Sequencing, Humans, Rare Diseases, Sequence Analysis, DNA, Translational Research, Biomedical |
Abstract | The introduction of exome sequencing in the clinic has sparked tremendous optimism for the future of rare disease diagnosis, and there is exciting opportunity to further leverage these advances. To provide diagnostic clarity to all of these patients, however, there is a critical need for the field to develop and implement strategies to understand the mechanisms underlying all rare diseases and translate these to clinical care. |
DOI | 10.1016/j.cell.2019.02.040 |
Alternate Journal | Cell |
PubMed ID | 30901545 |
Grant List | FDN-154279 / / CIHR / Canada U01 DE024427 / DE / NIDCR NIH HHS / United States UM1 HG009421 / HG / NHGRI NIH HHS / United States R24 HL123879 / HL / NHLBI NIH HHS / United States UM1 HL098166 / HL / NHLBI NIH HHS / United States |
A Diagnosis for All Rare Genetic Diseases: The Horizon and the Next Frontiers.
Similar Publications
Deep sequencing of candidate genes identified 14 variants associated with smoking abstinence in an ethnically diverse sample. Sci Rep. 2024;14(1):6385. | .
FAIR Header Reference genome: a TRUSTworthy standard. Brief Bioinform. 2024;25(3). | .
Gut Microbiota and Blood Metabolites Related to Fiber Intake and Type 2 Diabetes. Circ Res. 2024;134(7):842-854. | .